Conference
A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)
Authors
Bekaii-Saab T; Starodub A; El-Rayes B; O'Neil B; Shahda S; Ciombor K; Noonan A; Hanna W; Sehdev A; Shaib W
Volume
28
Publisher
OXFORD UNIV PRESS
Publication Date
June 1, 2017
Name of conference
ESMO 19th World Congress on Gastrointestinal Cancer
Conference place
SPAIN, Barcelona
Conference start date
June 28, 2017
Conference end date
July 1, 2017
Conference proceedings
ANNALS OF ONCOLOGY
ISSN
0923-7534